---
title: "Securitize Secures SEC Form S-4 Approval for SPAC Merger, Shareholder Vote Set for June 29"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289004616.md"
description: "Securitize has received SEC Form S-4 approval for its SPAC merger with Cantor Equity Partners II, with a shareholder vote scheduled for June 29. Upon approval, the combined entity will list on the NYSE as Securitize Corp under ticker SECZ. Additionally, tokenized real-world assets reached $32 billion in May, up 220% year-over-year."
datetime: "2026-06-08T05:14:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289004616.md)
  - [en](https://longbridge.com/en/news/289004616.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289004616.md)
---

# Securitize Secures SEC Form S-4 Approval for SPAC Merger, Shareholder Vote Set for June 29

Securitize, which has $4 billion in assets under management, has received SEC Form S-4 approval for its planned SPAC merger with Cantor Equity Partners II. According to NS3.AI, shareholders are scheduled to vote on the deal on June 29. If shareholders approve the transaction, the combined company is expected to list on the New York Stock Exchange as Securitize Corp under the ticker SECZ. Separately, RWA.xyz data shows the total on-chain value of tokenized real-world assets reached $32 billion in May, representing an increase of around 220% over the previous 12 months.

### Related Stocks

- [SECZ.US](https://longbridge.com/en/quote/SECZ.US.md)
- [NA.US](https://longbridge.com/en/quote/NA.US.md)
- [CEPT.US](https://longbridge.com/en/quote/CEPT.US.md)

## Related News & Research

- [XFLT Board Urges Shareholders to Vote FOR Approval of King Street Sub-Adviser Ahead of August 6th Special Meeting | XFLT Stock News](https://longbridge.com/en/news/294696736.md)
- [SkinHealth Systems sets virtual special shareholder meeting](https://longbridge.com/en/news/294550665.md)
- [Sadot Group announces annual shareholder meeting via webcast](https://longbridge.com/en/news/294551585.md)
- [Shengfeng Development shareholder Q&A addresses Nasdaq listing concerns ahead of Aug. 25 vote](https://longbridge.com/en/news/294341125.md)
- [Why Replimune (REPL) Is Up 15.5% After Supportive FDA Panel Vote On IGNYTE Melanoma Data](https://longbridge.com/en/news/294586250.md)